Track topics on Twitter Track topics that are important to you
Central obesity, core of metabolic syndrome, has been recognized as one of the rooting factors for development of diabetes and cardiovascular disease. Although efforts have been devoted to the studies of central obesity and/or metabolic syndrome, much remained unknown as to how obesity influences cellular as well as cardiac functions, what is the central regulation of one's body weight.
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders in obese individuals. Previous studies have demonstrated that weight loss by 5% of initial weight universally provide substantial benefits in these subjects. However, there are little integrated research teams, composed of different disciplines, share common weight reduction program to look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome. The significances of this proposal we plan to target, namely Rho kinase activity from peripheral leukocyte, several cardiac functions measured by noninvasive technique (VP-2000) and MRI, circulating brain-derived neurotrophic factors (BDNF) levels, are fully explained detailed in each sub-proposal.
In order to accomplish this integrated proposal, we will form research teams including endocrinologists, cardiologists, radiologists, and a coordinating data center. We pan to recruit 40 non-diabetic individuals with metabolic syndrome to participate this 12-16 weeks weight reduction program. Twenty-five age, sex matched non-diabetes lean will be served as controls. Oral glucose tolerance test, fasting blood obtained, noninvasive vascular and MRI examinations will be applied before and after weight reduction program in those achieving at least 5% loss of initial weight.
In summary, this study will investigate the effects of weight loss on (1) Rho kinase activity obtained from peripheral leukocyte; (2). Aortic stiffness, central aortic pressure and hemodynamic by a noninvasive vascular profiling system (VP-2000); (3) Brain function specifically reflecting by circulating BDNF; (4). Aortic elastic properties and left ventricular function by using MRI examinations, in non-diabetic individuals of metabolic syndrome.
Obesity, in particular central obesity, has been one of the important documented risk factors for development of diabetes and cardiovascular disease. Recent re-delineated various versions of definitions of metabolic syndrome, has fueled further the critical involvement of central adiposity in these disorders through several facets, including many increased circulating pro-inflammatory cytokines, directly or indirectly linking to visceral adipose tissue expressions. Although lots of efforts have been devoted to the studies of central obesity and/or metabolic syndrome, much remained unknown as to how obesity affect cellular as well as cardiac function, what is the central regulation of one's body weight, and how to measure fat in visceral organs precisely.
Weight loss is an undisputed way to improve cardiovascular and metabolic disorders. Both a recent review article and data from us demonstrated that only weight loss by 5% of initial weight universally delivered benefits on obese individuals. However, there is little integrated research teams from different disciplines share common weight reduction protocol and look at different aspects of weight reduction in non-diabetic individuals with metabolic syndrome. The significances of this proposal we plan to target are explained in detail in each sub-proposal. However, we would like to make a briefing description here.
1. . Rho kinase (ROCK) is a serine/threonine kinase that mediates the downstream signaling of the small guanosine triphosphate- binding protein, Rho, on the actin cytoskeleton. In mostly animal models, the inhibition of ROCK ameliorates many cardiovascular conditions, including hypertension, atherosclerosis, myocardial fibrosis, and stroke. Recent study from Taiwan showed that ROCK activity is increased in patients with metabolic syndrome.
2. . Obese and overweight individuals have increased levels of arterial stiffness which is a measure of aortic and large vessel distensibility or compliance. Weight loss could induce significant reduction in sympathetic activity and blood pressure. However, little is known as whether weight loss can improve arterial stiffness, central aortic blood pressure and related hemodynamics.
3. . Brain-derived neurotrophic factor (BDNF), recently reported related to Alzheimer's disease, is present in brain tissues extensively. It is also noted that low circulating level of BDNF was associated with impaired glucose metabolism, and might be associated higher BMI or body fat. We are interesting in effect of weight reduction on circulating BDNF values in non-diabetic subjects with metabolic syndrome.
4. . Magnetic resonance imaging (MRI) of the heart is frequently used and can provide accurate and reproducible measurement of LV mass, volumes, systolic function and aortic pulse velocity. Although echo-cardiography has been applied to study effect of weight loss on cardiac function, there has been no study by using cardiac MRI to measure cine images of cardiac function and related variables before and after weight reduction in non-diabetic subjects with metabolic syndrome.
In order to accomplish this integrated proposal, we will formulate research teams including endocrinologists, cardiologists, radiologists, and a data center, coordinated by a PhD researcher (infra-structure as described below). We will recruit 40 non-diabetic individuals with metabolic syndrome (fulfilled the criteria from IDF, 2006 and DOH of Taiwan). Twenty-five age, sex matched non-diabetes lean will be served as controls.
Written informed consent will be obtained from each subject before being enrolled into the study after approval from IRB of Taichung VGH, Taichung, Taiwan. This weight reduction program will be assisted by experienced dieticians and sports experts, all of whom we had collaborated and published article previously. This program will last for 12-16 weeks with every participants join together courses 4 hours per week. Each participant will be introduced a dietary plan based on a caloric reduction of 1200 Kcal/day from the values thought necessary to maintain their usual weight. Subject will be asked to follow dietary advice and their eating habit will be reviewed by dietician at the time of their weekly visit. Activity levels will be encouraged to reach 30 min each day and at least 5 days a week. During each visit, weight of each participant will be recorded and announced. Meals replacement may considered for those did not get much improvement during weekly monitoring since recent report indicated that meals replacement may provide certain help in reducing body weight. We are confident that adequate weight reduction (at least 5% of initial weight) and good compliance will be achieved given our previous experience.
In aggregate, this study will investigate the effects of weight loss on (1) Rho kinase activity obtained from peripheral leukocyte (2). Aortic stiffness, central aortic pressure and hemodynamic by a noninvasive technique (3) Brain function specifically reflecting by circulating BDNF levels (4). Aortic elastic properties and left ventricular function by using MRI examinations, in non-diabetic individuals of metabolic syndrome. Findings from this integrated proposal will provide valuable information as mild to moderate weight loss (5% of initial body weight) in cellular, cardiac and central nervous system in additional to well-known effects on lipids, inflammatory cytokines and insulin resistance in non-diabetic subjects with metabolic syndrome.
Follow up- Subjects received physical check up, fasting blood tests and OGTT 6 and 12 months after the end of study.
Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Taichung Veterans General Hospital
Taichung Veterans General Hospital
Published on BioPortfolio: 2014-08-27T03:16:01-0400
The aim of this study is to identify the psychological, emotional and lifestyle variables that can have an influence on the different components of metabolic syndrome (MetS) and develop a ...
To evaluate the effects of flaxseed supplementation on fasting blood sugar, lipid profile and anthropocentric measurements in subjects with metabolic syndrome, in a randomized, open-labele...
To evaluate the effectiveness of Caduet in addition to therapeutic life-style change (TLC) intervention in resolving metabolic syndrome fifty three individuals were randomized to TLC inter...
The investigators compared the effectiveness of a lifestyle intervention program carried out by trained professionals versus standard unstructured information on healthy lifestyle given by...
A healthy diet and exercise have improved the health of people without HIV who have Metabolic Syndrome. In this study we would like to find out if the same benefit can be seen in people w...
The increasing prevalence of metabolic syndrome (MetS) in childhood makes lifestyle interventions imperative during adolescence. This study aimed to assess the effects of a community-based lifestyle i...
In HIV-infected patients on combination antiretroviral therapy (cART), lipodystrophy shares many similarities with metabolic syndrome, but only metabolic syndrome has objective classification criteria...
Effectiveness on maternal and offspring metabolic control of a home-based dietary counseling intervention and DHA supplementation in obese/overweight pregnant women (MIGHT study): A randomized controlled trial-Study protocol.
Lifestyle interventions are the primary prevention strategy for gestational diabetes (GDM) in obese/overweight women; however, these interventions have shown limited effectiveness. Omega-3 polyunsatur...
The risk of metabolic syndrome can be influenced by inadequate vitamin D levels, and exposure to sunlight is the main external source of vitamin D. The present study assessed the influence of environm...
Individuals with major psychotic disorders such as schizophrenia are at increased risk for developing metabolic syndrome due to lifestyle- and treatment-related factors. Numerous interventions have be...
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Counseling during which a professional plays an active role in a client's or patient's decision making by offering advice, guidance, and/or recommendations.
Counseling conducted via electronic or other non-face-to-face interactions.
ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...